Medpace Holdings, Inc. Share-based Payment Arrangement, Expense
Medpace Holdings, Inc. (MEDP) reported Share-based Payment Arrangement, Expense of $981.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2017-10-31
- Medpace Holdings, Inc. share-based payment arrangement, expense for the quarter ending 2017-09-30 was $981.00K, a 77.10% decline year-over-year.
- Medpace Holdings, Inc. share-based payment arrangement, expense for the quarter ending 2017-06-30 was $1.20M, a 63.26% decline year-over-year.
- Medpace Holdings, Inc. share-based payment arrangement, expense for the quarter ending 2017-03-31 was $1.03M, a 2.48% increase year-over-year.
- Medpace Holdings, Inc. share-based payment arrangement, expense for the quarter ending 2016-12-31 was $1.26M, a 88.03% decline year-over-year.
- Medpace Holdings, Inc. share-based payment arrangement, expense for fiscal 2016 was $9.81M, a 56.03% decline from fiscal 2015.
- Medpace Holdings, Inc. share-based payment arrangement, expense for fiscal 2015 was $22.32M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2017-09-30 | $981.00K 10-Q · filed 2017-10-31 | $2.18M derived: sum of 2 quarters · filed 2017-10-31 | $3.21M 10-Q · filed 2017-10-31 | $4.47M derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | $1.20M 10-Q · filed 2017-08-01 | $2.23M 10-Q · filed 2017-08-01 | $3.49M derived: sum of 3 quarters · filed 2017-08-01 | $7.77M derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-03-31 | $1.03M 10-Q · filed 2017-05-02 | $2.29M derived: sum of 2 quarters · filed 2017-05-02 | $6.57M derived: sum of 3 quarters · filed 2017-10-31 | $9.84M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $5.54M derived: sum of 2 quarters · filed 2017-10-31 | $8.81M derived: sum of 3 quarters · filed 2017-10-31 | $9.81M 10-K · filed 2017-02-28 |
| 2016-09-30 | $4.28M 10-Q · filed 2017-10-31 | $7.55M derived: sum of 2 quarters · filed 2017-10-31 | $8.56M 10-Q · filed 2017-10-31 | $19.05M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | $3.27M 10-Q · filed 2017-08-01 | $4.28M 10-Q · filed 2017-08-01 | $14.77M derived: sum of 3 quarters · filed 2017-08-01 | $21.69M derived: sum of 4 quarters · filed 2017-08-01 |
| 2016-03-31 | $1.01M 10-Q · filed 2017-05-02 | $11.50M derived: sum of 2 quarters · filed 2017-05-02 | $18.43M derived: sum of 3 quarters · filed 2017-05-02 | |
| 2015-12-31 | $10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $17.42M derived: sum of 2 quarters · filed 2017-02-28 | $22.32M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $6.93M 10-Q · filed 2016-11-03 | $11.83M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $5.42M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |